Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients

BACKGROUND: Diabetes mellitus is a chronic metabolic disorder of hyperglycemia. Chronic hyperglycemia produces advanced glycation end products such as the methylglyoxal (MGO) which interferes with cell functions, insulin signaling, and β-cell functions. The present study was conducted to determine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Memon, Muhammad Ayoob, Khan, Raisa Noor, Riaz, Saman, Ain, Qurat Ul, Ahmed, Masood, Kumar, Naresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327683/
https://www.ncbi.nlm.nih.gov/pubmed/30693045
http://dx.doi.org/10.4103/jrms.JRMS_1078_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327683/
https://www.ncbi.nlm.nih.gov/pubmed/30693045
http://dx.doi.org/10.4103/jrms.JRMS_1078_17

Ejemplares similares